Pre-lung transplant ECMO was not independently associated with an increased CPRA when
adjusting for PRBC transfusion. Where clinically appropriate, transfusions should
be limited in these patients.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Seminars in Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sensitization from transfusion in patients awaiting primary kidney transplant.Nephrology Dialysis Transplantation. 2013; 28: 2908-2918https://doi.org/10.1093/ndt/gft362
- Prior Human Leukocyte Antigen-Allosensitization and Left Ventricular Assist Device Type Affect Degree of Post-implantation Human Leukocyte Antigen-Allosensitization.J Heart Lung Transplant. 2009; 28: 838-842https://doi.org/10.1016/j.healun.2009.04.031
- HLA Sensitization in Pediatric Pre-transplant Cardiac Patients Supported by Mechanical Assist Devices: the Utility of Luminex.J Heart Lung Transplant. 2009; 28: 123-129https://doi.org/10.1016/j.healun.2008.11.908
- Human Leukocyte Antigen Sensitization in Lung Transplant Candidates Supported by Extracorporeal Membrane Oxygenation.Am J Respir Crit Care Med. 2013; 188: 627-628https://doi.org/10.1164/rccm.201303-0428LE
- HLA Allosensitization in ECMO as a Bridge to Lung Transplantation.J Heart Lung Transplant. 2013; 32: S170https://doi.org/10.1016/j.healun.2013.01.405
Article info
Publication history
Published online: September 28, 2022
Publication stage
In Press Journal Pre-ProofFootnotes
Funding: The authors have no funding to report.
Disclosures: The authors have no disclosures to report.
IRB Approval: This retrospective study was approved on October 26, 2020 (Protocol #825580) by the University of Pennsylvania International Review Board.
Informed Consent: This study was deemed exempt from informed consent per the IRB approved protocol above.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
